AN UNBIASED VIEW OF AGO TUMOR

In summary, throughout the last decade probably the most amazing advantage has been realized in HER2/neu-overexpressing MBC. Introduction of bevacizumab being a VEGF-directed specific cure continues to be an issue on discussion. A number of the novel therapeutics for the breast cancer armamentarium resulted in prolongation of survival for people wi